COVID-PREVENT - Effect of anticoagulation therapy on clinical outcomes in COVID-19
| Institution | Charité - Universitätsmedizin Berlin |
|---|---|
| Project leader | Ulf Landmesser |
| Site | Berlin |
| Project type | Klinische Studie |
| Funding | € 321.476,19 |
| Begin | 01.07.2020 |
| End | 31.12.2022 |
Förderkennzeichen
81X1100222
Projektnummer
1219